Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...
Sinar Daily on MSN12d
Malaysia Advocates Early Detection, Advanced Therapies For Prostate CancerProstate cancer stands as the third most common cancer among Malaysian men, with 70 percent of cases diagnosed at advanced ...
Hosted on MSN7mon
Radioligand therapy extends progression-free survival with manageable safety profile in advanced prostate cancerNew data on prolonged prostate-specific ... resistant prostate cancer (mCRPC). This study was presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 Annual Meeting and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback